Episode 390: Starting Over in Retina Practice with Drs. Steve Christiansen, Alex Ringeisen, and Sarwar Zahid
Episode 389: May 2023 Retinal Physician Preview, Wide-Field Photos instead of a Fundus Exam, Home Monitoring for AMD, Big Data in Retina Practice, Stem Cell for Retinal Diseases
Episode 388: Conversations from the 2023 Vit-Buckle Society Meeting
Episode 387: Ophthalmology Residency Post-Match Panel Part Two: Focus on Rank Lists, Open Houses, and the Match Algorithm
Episode 386: Artificial Intelligence, ChatGPT, and More with Dr. Patrick O'Shea
Episode 385: April 2023 Retinal Physician Preview, Incorporating Intravitreal Injections for Geographic Atrophy into Retina Practices
Episode 384: Ophthalmology Residency Post-Match Panel Part One: Focus on Applications and Interviews
Episode 383: Dr. Glaucomflecken discusses his career, new podcast and projects, and health insurance company criticisms
Episode 382: Journal Club Including Access to Eye Care in the United States, Perceptions of Parental Leave, U.S. Health Insurance Payments
Episode 381: March 2023 Retinal Physician Discussion Focusing on Gene Therapy and Optogenetics
Episode 380: Ocular Oncology, Retina Extracurriculars, and the Job Search
Breaking Story: FDA Approves SYFOVRE™ for Geographic Atrophy with commentary by Dr. Allen Ho
Episode 379: Planning an Academic Meeting (VBS) and Residency Application Review with Drs. Avni Finn and Basil William
Episode 378: Journal Club Discussion Including PVDs and Complications, TRDs and Follow-up, Ranibizumab versus Bevacizumab for ROP, Patient Satisfaction Metrics Editorial
Episode 377: February 2023 Retinal Physician Discussion Focusing on Geographic Atrophy
Episode 376: Life After Fellowship
Episode 375: Journal Club on Google Results for "Eye Doctor", Complications after Posterior Vitreous Detachment, Research Funding and Industry Payments, LGBTQ+ Association with Burnout
Episode 374: The Silicone Oil Podcast
Episode 373: January 2023 Retinal Physician Discussion Focusing on Coding for Geographic Atrophy Injections, Private Equity Perspectives, Biomarkers and Early Worsening for Diabetic Retinopathy,
Episode 372: Retina Postoperative Fundamentals
